Self-Expanding Evolut Valves Edge Out Sapien in Majority-Female TAVR Trial
(MedPage Today) -- ATLANTA -- For transcatheter aortic valve replacement (TAVR) candidates with a small aortic annulus, the two leading platforms offered differing hemodynamic valve performances despite being similarly effective at 1 year, according... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2024 Category: Cardiology Source Type: news
The 'quick' at-home workouts that will blast stubborn belly fat in just weeks
Having a large amount of belly fat could mean you are at higher risk for dangerous health conditions such as diabetes and heart disease. (Source: Daily Express - Health)
Source: Daily Express - Health - April 8, 2024 Category: Consumer Health News Source Type: news
Semaglutide Beneficial in HFpEF Patients With Diabetes Semaglutide Beneficial in HFpEF Patients With Diabetes
In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 8, 2024 Category: Internal Medicine Tags: Cardiology Source Type: news
DR MAX PEMBERTON: There's no magic pill for nightmares, but this is the one thing I prescribe to every patient for better sleep
You wake up in a cold sweat, panting, your heart racing. You scan the dark room. Nothing. Reassured, you relax: it was just a nightmare. But that feeling of horror lingers and you struggle to fall asleep. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2024 Category: Consumer Health News Source Type: news
Ticagrelor Alone Cuts Bleeding Without More Events Post-PCI Ticagrelor Alone Cuts Bleeding Without More Events Post-PCI
Ticagrelor monotherapy safely cut bleeding by more than half after intervention for acute coronary syndrome, without an increase in MACCE, in the ULTIMATE-DAPT trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 8, 2024 Category: Neurology Tags: Cardiology Source Type: news
Chelation Therapy Provides No Benefit Post-MI Chelation Therapy Provides No Benefit Post-MI
Chelation therapy to remove potentially toxic levels of lead was not associated with a reduction in CV events in post-MI patients with diabetes in the TACT2 trial.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 7, 2024 Category: Endocrinology Tags: Cardiology Source Type: news
Telemedicine Reduces Readmission in Post-PCI ACS Patients Telemedicine Reduces Readmission in Post-PCI ACS Patients
A telemedicine program for patients with acute coronary syndrome discharged after percutaneous coronary intervention improved outcomes significantly compared with standard care.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Wegovy Helps HFpEF Patients With Diabetes Mellitus
(MedPage Today) -- ATLANTA -- Weight loss and heart failure benefits with semaglutide (Wegovy) extended to patients with obesity-related heart failure with preserved ejection fraction (HFpEF) who have type 2 diabetes, the STEP-HFpEF DM trial showed... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 7, 2024 Category: Cardiology Source Type: news
Beta blockers help only HALF of heart attack patients, landmark trial finds
Around 60,000 people are prescribed beta blockers every year in the UK. But a trial has found that, for about half of patients, they do not reduce the risk of death or further heart attacks. (Source: the Mail online | Health)
Source: the Mail online | Health - April 7, 2024 Category: Consumer Health News Source Type: news
Mandibular Device Comparable to CPAP to Reduce BP Mandibular Device Comparable to CPAP to Reduce BP
A mandibular advancement device was non-inferior to standard of care CPAP to reduce blood pressure in patients with hypertension and sleep apnea in the CRESCENT trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock
The results, specific to STEMI patients with cardiogenic shock, are striking, experts say, but much work lies ahead. ATLANTA, GA—For patients with acute MI complicated by cardiogenic shock (AMICS), the routine use of mechanical circulatory support (MCS) with the Impella CP (Abiomed) microaxial…#atlanta #amics #impellacpabiomed #dangershock #jacobeifermøller #phd #denmark #acc #nejm #sunilvrao (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
Massachusetts city is set to settle a lawsuit in the death of an opioid-addicted woman
Relatives of a Vermont woman whose obituary drew national attention for its candid and heart-breaking discussion of her opioid addiction appear to have reached a settlement in a lawsuit over her death (Source: ABC News: Health)
Source: ABC News: Health - April 7, 2024 Category: Consumer Health News Tags: Health Source Type: news
Impella CP Improves Survival in STEMI, Cardiogenic Shock Impella CP Improves Survival in STEMI, Cardiogenic Shock
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Impella Saves Live in CS, but Patient Selection Key Impella Saves Live in CS, but Patient Selection Key
In the first randomized trial of Impella in a select group of patients with AMI and cardiogenic shock, the device saved lives. The high rate of serious adverse events calls us to pay attention to the nuances of the data, says John Mandrola, MD.theheart.org on Medscape (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 7, 2024 Category: Intensive Care Tags: Cardiology Commentary Source Type: news
Impella Saves Lives in CS, but Patient Selection Key Impella Saves Lives in CS, but Patient Selection Key
In the first randomized trial of Impella in a select group of patients with AMI and cardiogenic shock, the device saved lives. The high rate of serious adverse events calls us to pay attention to the nuances of the data, says John Mandrola, MD.theheart.org on Medscape (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 7, 2024 Category: Emergency Medicine Tags: Cardiology Commentary Source Type: news
